Ureidopiperidine derivatives as selective human NK3 receptor antagonists
US6465489B1 · kind B1 · utility
4Cited by
4References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 5, 2001 |
| Grant date | Oct 15, 2002 |
| Priority date | — |
| Expiry date | Apr 5, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/55
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns compounds of formula (I) in racemic or optically pure form, methods for obtaining them and pharmaceutical compositions containing same. Said compounds are selective NK3 receptor antagonists.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.